Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  12121 of 12268  at  7/4/2020 11:22:45 AM  by

frnktofini


Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients

 Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19.
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 144
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...